86 / 1816
22
Predicted absolute benefit: Large (20+ %)
Predicted absolute benefit: Intermediate (10-19%)
Predicted absolute benefit: Lower (<10%)
1924 pN0 women
3763 pN0 women
1600 pN0 women
Observed
absolute
breast cancer mortality
benefit
in pN0 women by size of absolute
recurrence
benefit
Lancet, 2011
Large Intermediate Lower